Project: A novel diagnostic Biosensor for ALK-targeted therapy of non-small cell lung cancer (NSCLC)

Acronym BIOSTAR17 (Reference Number: 11375)
Duration 01/10/2017
Project Topic Worldwide, lung cancer is the leading cause of cancer-related deaths (20% of total) with NSCLC as the most common type. BIOSTAR aims to market an innovative chip-based biosensor as companion diagnostic (CD) for the detection of the EML4-ALK biomarker as a prerequisite for the selection and the subsequent monitoring of ALK-targeted therapy in NSCLC treatment. Our biosensor will be superior to conventional detection methods by combining high-sensitivity, cost-effectiveness and usability.
Network Eurostars 2
Call Eurostars Cut-Off 7

Project partner

Number Name Role Country
1 InnoPharmaScreen Inc. Coordinator Korea, Republic of
2 ASAN Medical Center Partner Korea, Republic of
3 AptaIT GmbH Partner Germany
4 NeoVentures Biotechnology Inc. Partner Canada
5 Fraunhofer Gesellschaft Partner Germany